Literature DB >> 29771385

Outpatient Parenteral Antimicrobial Therapy in Young Infants.

Nathan M Krah1, Jared Olson2, Emily A Thorell1, Lawanda Esquibel1, Russell J Osguthorpe1, Andrew T Pavia1, Adam L Hersh1.   

Abstract

We examined clinical outcomes for 53 young infants (<3 months of age) treated with outpatient parenteral antimicrobial therapy after discharge from a freestanding children's hospital. None of the patients experienced treatment failure or disease progression; 9% of them experienced a catheter-related complication, but this percentage is not different than that for older children.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29771385     DOI： 10.1093/jpids/piy002

Source DB:  PubMed          Journal:  J Pediatric Infect Dis Soc        ISSN： 2048-7193            Impact factor:   3.164


  4 in total

1.  Economic Burden of Home Antimicrobial Therapy: OPAT Versus Oral Therapy.

Authors:  Nathan M Krah; Tyler Bardsley; Richard Nelson; Lawanda Esquibel; Mark Crosby; Carrie L Byington; Andrew T Pavia; Adam L Hersh
Journal:  Hosp Pediatr       Date:  2019-04

2.  First Pediatric Outpatient Parenteral Antibiotic Therapy Clinic in Indonesia.

Authors:  Aryono Hendarto; Nina Dwi Putri; Dita Rizkya Yunita; Mariam Efendi; Ari Prayitno; Mulya Rahma Karyanti; Hindra Irawan Satari; Sri Rezeki S Hadinegoro; Monica Chan
Journal:  Front Pediatr       Date:  2020-04-15       Impact factor: 3.418

3.  Being 'at-home' on outpatient parenteral antimicrobial therapy (OPAT): a qualitative study of parents' experiences of paediatric OPAT.

Authors:  Bernie Carter; Debra Fisher-Smith; David Porter; Steven Lane; Matthew Peak; David Taylor-Robinson; Louise Bracken; Enitan Carrol
Journal:  Arch Dis Child       Date:  2019-09-26       Impact factor: 3.791

4.  Paediatric Outpatient Parenteral Antimicrobial Therapy (OPAT): An e-survey of the experiences of parents and clinicians.

Authors:  Bernie Carter; Debra Fisher-Smith; David Porter; Steven Lane; Matthew Peak; David Taylor-Robinson; Louise Bracken; Enitan D Carrol
Journal:  PLoS One       Date:  2021-04-02       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.